Contact
Please use this form to send email to PR contact of this press release:
Human medicines European public assessment report (EPAR): Zolsketil pegylated liposomal, doxorubicin, Ovarian Neoplasms;Sarcoma, Kaposi;Multiple Myeloma, Date of authorisation: 31/05/2022, Revision: 1, Status: Authorised
TO: